BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7016490)

  • 21. Studies on glycolytic enzymes in relation to cancer. 3. Clinical significance of serum phosphohexose isomerase and aldolase in cancer of the prostate. A comparative study with serum acid phosphatase and serum alkaline phosphatase.
    Damle SR; Talavdekar RV; Panse TB
    Indian J Cancer; 1971 Sep; 8(3):176-84. PubMed ID: 5141722
    [No Abstract]   [Full Text] [Related]  

  • 22. [Significance of an immunoenzyme assay of the prostate-specific acid phosphatase (PAP) (E.C.3.1.3.2.) in prostatic carcinoma. Methods and initial clinical results].
    Bauer HW; Schmiedt E
    Urologe A; 1983 Sep; 22 Suppl():367-71. PubMed ID: 6195796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer].
    Akimoto S; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1988 Dec; 34(12):2143-8. PubMed ID: 2467543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunological colorimetric determination of serum prostatic acid phosphatase activity in patients with prostatic diseases comparing with RIA and Kind-King modified methods].
    Hayashi Y; Saionji K; Kitagawa R; Iizuka K; Higurashi H
    Rinsho Byori; 1985 Sep; 33(9):1031-40. PubMed ID: 3908752
    [No Abstract]   [Full Text] [Related]  

  • 25. [Acid phosphatases].
    Chiche R; Steg A
    Sem Hop; 1983 Jun; 59(22):1709-16. PubMed ID: 6308797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunoenzyme assay for prostate-specific acid phosphatase in prostatic cancer].
    Bauer HW
    Med Welt; 1982 Nov; 33(46):1616-21. PubMed ID: 6185820
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of prostatic acid phosphatase assays.
    Wise WS; Kandaswamy K
    Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A solid-phase radioimmunoassay for human prostatic acid phosphatase.
    Foti AG; Herschman H; Cooper JF
    Cancer Res; 1975 Sep; 35(9):2446-52. PubMed ID: 1170944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prostatic acid phosphatase by enzymeimmunoassay].
    Masukagami T; Ando K; Shimazaki J
    Hinyokika Kiyo; 1984 Nov; 30(11):1691-5. PubMed ID: 6084950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of manipulation of the prostate gland on serum prostate-specific acid phosphatase measured by radioimmunoassay.
    Vihko P; Lukkarinen O; Kontturi M; Vihko R
    Invest Urol; 1981 Mar; 18(5):334-6. PubMed ID: 6162819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Enzymological study of prostatic cancer. II. Serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase activity and lactic dehydrogenase isoenzymes in prostatic cancer, with special reference to relation with stage and histological malignancy].
    Ishibe T; Nihira H; Mori K
    Hinyokika Kiyo; 1969 Apr; 15(4):254-65. PubMed ID: 5817349
    [No Abstract]   [Full Text] [Related]  

  • 32. [The acid and alkaline phosphatase activity in the serum of patients with prostatic cancer. The effect of endocrine therapy].
    Thijs LG; Poelman JR; Noll WL
    Ned Tijdschr Geneeskd; 1969 Jul; 113(30):1303-9. PubMed ID: 5802998
    [No Abstract]   [Full Text] [Related]  

  • 33. Acid phosphatase.
    Henneberry MO; Engel G; Grayhack JT
    Urol Clin North Am; 1979 Oct; 6(3):629-41. PubMed ID: 388794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tissue polypeptide antigen as a marker for prostatic neoplasms. Preliminary study].
    Ruibal A; DurĂ¡n P; Ibarz L; Fraile M; Roca I; de Torres Mateos JA
    Arch Esp Urol; 1984; 37(5):399-403. PubMed ID: 6517625
    [No Abstract]   [Full Text] [Related]  

  • 35. Prostatic acid phosphatase: its current clinical status.
    Heller JE
    J Urol; 1987 Jun; 137(6):1091-103. PubMed ID: 3295298
    [No Abstract]   [Full Text] [Related]  

  • 36. [Enzymological study of prostatic cancer. VI. Serum acid phosphatase level and prognosis of patients with prostatic carcinoma (author's transl)].
    Ishibe T
    Nihon Hinyokika Gakkai Zasshi; 1974 Feb; 65(2):102-7. PubMed ID: 4471809
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical significance of serum and bone marrow acid phosphatase.
    Pontes JE
    Prostate; 1980; 1(4):465-70. PubMed ID: 7024959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoenzyme assay for human prostatic acid phosphatase.
    Choe BK; Rose NR; Korol M; Pontes EJ
    Proc Soc Exp Biol Med; 1979 Dec; 162(3):396-400. PubMed ID: 390535
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical studies of prostatic antigens(gamma-seminoprotein, beta-microseminoprotein). II. Measurement of serum prostatic antigens (gamma-seminoprotein, beta-microseminoprotein) by radioimmunoassay].
    Okabe T; Eto K
    Nihon Hinyokika Gakkai Zasshi; 1983 Aug; 74(8):1320-5. PubMed ID: 6202916
    [No Abstract]   [Full Text] [Related]  

  • 40. Prostatic acid phosphatase as measured with two radioimmunoassay kits in the detection of prostatic adenocarcinoma.
    Brody JP; Savory J; Sturgill BC; Lehman MR; Wills MR
    Clin Chem; 1981 Apr; 27(4):605-7. PubMed ID: 7471429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.